Abstract
With the price of prescription drugs increasing rapidly, Ameet Sarpatwari, Jerry Avorn, and Aaron Kesselheim explore the ways US public funding supports drug development and identify policy reforms to help ensure that patients can affordably access therapies arising from such support
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have